15087-02-2
15087-02-2 structure
- Name: β-Estradiol 17-(β-D-glucuronide) sodium salt
- Chemical Name: sodium,3,4,5-trihydroxy-6-[(3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl)oxy]oxane-2-carboxylic acid
- CAS Number: 15087-02-2
- Molecular Formula: C24H31NaO8
- Molecular Weight: 470.5
- Catalog: Research Areas Endocrinology
- Create Date: 2017-07-30 23:51:42
- Modify Date: 2026-07-03 12:03:36
-
Estradiol 17-(β-D-Glucuronide) sodium, a metabolite of estrogen, is well known to cause intrahepatic cholestasis in humans[1].
| Name | sodium,3,4,5-trihydroxy-6-[(3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl)oxy]oxane-2-carboxylic acid |
|---|---|
| Synonyms |
1, 3, 5-ESTRATRIEN-3, 17β-DIOL 17-GLUCOSIDURONATE SODIUM SALT
3,17BETA-DIHYDROXY-1,3,5-ESTRATRIENE 17-GLUCURONIDE SODIUM SALT BETA-ESTRADIOL 17-(BETA-D-GLUCURONIDE) SODIUM SALT oestradiol 17-(beta-D-glucuronide), sodium salt Clazuril Impurity3 (Clazuril ImpurityC) 17-BETA-ESTRADIOL 17-GLUCURONIDE SODIUM SALT Hexopyranosiduronic acid, 3-hydroxyestra-1,3,5(10)-trien-17-yl, sodium salt (1:1) 1,3,5-ESTRATRIENE-3,17BETA-DIOL 17-GLUCURONIDE SODIUM SALT Estradiol 17-O-β-D-glucuronide, sodium salt Estradiol Impurity 14 β-Estradiol 17-(β- D -glucuronide) sodium salt 1,3,5-Estratriene-3,17β-diol 17-glucuronide, 3,17β-Dihydroxy-1,3,5-estratriene 17-glucuronide B-ESTRADIOL 17-(B-D-GLUCURONIDE)SODIUM sodium 3-hydroxyestra-1,3,5-trien-17β-yl-β-D-glucopyranosuronate 3,17β-Dihydroxy-1,3,5-estratriene 17-glucuronide b-Estradiol 17-(b-D-glucuronide) sodium salt 17β-Estradiol 17-Glucuronide Sodium Salt sodium:(2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-[[(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]oxy]oxane-2-cboxylate Estradiol 17-(β-D-Glucuronide) sodium salt 1,3,5-Estratriene-3,17β-diol 17-glucuronide 1,3,5-ESTRATRIEN-3,17-BETA-DIOL 17-GLUCOSIDURONATE SODIUM SALT |
| Description | Estradiol 17-(β-D-Glucuronide) sodium, a metabolite of estrogen, is well known to cause intrahepatic cholestasis in humans[1]. |
|---|---|
| Related Catalog | |
| Target |
Human Endogenous Metabolite |
| References |
| Molecular Formula | C24H31NaO8 |
|---|---|
| Molecular Weight | 470.5 |
| Exact Mass | 470.19166222 |
| PSA | 136.68000 |
| LogP | 1.52570 |
| Storage condition | -20°C |
| Symbol |
GHS07, GHS08 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H312-H332-H351 |
| Precautionary Statements | P280 |
| Personal Protective Equipment | Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| Hazard Codes | Xn: Harmful; |
| Risk Phrases | R20/21/22 |
| Safety Phrases | S22 |
| RIDADR | NONH for all modes of transport |
|
~43%
15087-02-2 |
| Literature: Numazawa, Mitsuteru; Nagaoka, Masao; Tsuji, Masachika; Osawa, Yoshio Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1983 , # 1 p. 121 - 125 |
|
~%
15087-02-2 |
| Literature: Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), , # 1 p. 121 - 125 |
|
~%
15087-02-2 |
| Literature: Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), , # 1 p. 121 - 125 |
|
~%
15087-02-2 |
| Literature: Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), , # 1 p. 121 - 125 |
| Precursor 4 | |
|---|---|
| DownStream 1 | |